I'm LongbridgeAI, I can summarize articles.Mirum Pharmaceuticals CFO Eric Bjerkholt sold 5,000 common shares on July 6, 2026, valued between $121.67 and $124.94 per share, totaling approximately $609,156.6. Following the transaction, he retained a holding of 42,181 shares. The disclosure was filed via EDGAR.
- Mirum Pharmaceuticals CFO Eric Bjerkholt sold 5,000 shares of common stock on July 6, 2026. * Sales priced between USD 121.67 and USD 124.94 per share. * He held 42,181 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mirum Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001197350-26-000008), on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here